| Year |
Citation |
Score |
| 2010 |
Podbielska M, Dasgupta S, Levery SB, Tourtellotte WW, Annuk H, Moran AP, Hogan EL. Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid. Journal of Lipid Research. 51: 1394-406. PMID 20154333 DOI: 10.1194/Jlr.M001396 |
0.34 |
|
| 2007 |
Casserly G, Barry T, Tourtellotte WW, Hogan EL. Absence of Mycoplasma-specific DNA sequence in brain, blood and CSF of patients with multiple sclerosis (MS): a study by PCR and real-time PCR. Journal of the Neurological Sciences. 253: 48-52. PMID 17234214 DOI: 10.1016/J.Jns.2006.11.017 |
0.422 |
|
| 2006 |
Shah M, Smit TK, Morgello S, Tourtellotte W, Gelman B, Brew BJ, Saksena NK. Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage. Aids Research and Human Retroviruses. 22: 177-81. PMID 16478400 DOI: 10.1089/Aid.2006.22.177 |
0.318 |
|
| 2005 |
Zhang Y, Da RR, Hilgenberg LG, Tourtellotte WW, Sobel RA, Smith MA, Olek M, Nagra R, Sudhir G, van den Noort S, Qin Y. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. Journal of Neuroimmunology. 167: 120-30. PMID 16099056 DOI: 10.1016/J.Jneuroim.2005.05.006 |
0.351 |
|
| 2005 |
Zhang Y, Da RR, Guo W, Ren HM, Hilgenberg LG, Sobel RA, Tourtellotte WW, Smith MA, Olek M, Gupta S, Robertson RT, Nagra R, Van Den Noort S, Qin Y. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. Journal of Clinical Immunology. 25: 254-64. PMID 15981091 DOI: 10.1007/S10875-005-4083-5 |
0.322 |
|
| 2004 |
Gade-Andavolu R, Comings DE, MacMurray J, Vuthoori RK, Tourtellotte WW, Nagra RM, Cone LA. RANTES: a genetic risk marker for multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 10: 536-9. PMID 15471370 DOI: 10.1191/1352458504Ms1080Oa |
0.367 |
|
| 2004 |
Gade-Andavolu R, Comings DE, MacMurray J, Rostamkhani M, Cheng LS, Tourtellotte WW, Cone LA. Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 6: 126-31. PMID 15354329 DOI: 10.1097/01.Gim.0000127274.45301.54 |
0.362 |
|
| 2004 |
Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. The Journal of Comparative Neurology. 473: 128-36. PMID 15067723 DOI: 10.1002/Cne.20102 |
0.389 |
|
| 2003 |
Tajouri L, Mellick AS, Ashton KJ, Tannenberg AE, Nagra RM, Tourtellotte WW, Griffiths LR. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Research. Molecular Brain Research. 119: 170-83. PMID 14625084 DOI: 10.1016/J.Molbrainres.2003.09.008 |
0.348 |
|
| 2003 |
Qin Y, Duquette P, Zhang Y, Olek M, Da RR, Richardson J, Antel JP, Talbot P, Cashman NR, Tourtellotte WW, Wekerle H, Van Den Noort S. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 1081-8. PMID 12861047 DOI: 10.1097/01.Lab.0000077008.24259.0D |
0.348 |
|
| 2003 |
Kieseier BC, Pischel H, Neuen-Jacob E, Tourtellotte WW, Hartung HP. ADAM-10 and ADAM-17 in the inflamed human CNS. Glia. 42: 398-405. PMID 12730960 DOI: 10.1002/Glia.10226 |
0.379 |
|
| 2002 |
Mann MB, Wu S, Rostamkhani M, Tourtellotte W, MacMurray JP, Comings DE. Association between the phenylethanolamine N-methyltransferase gene and multiple sclerosis. Journal of Neuroimmunology. 124: 101-105. PMID 11958827 DOI: 10.1016/S0165-5728(02)00009-7 |
0.347 |
|
| 2002 |
Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. The New England Journal of Medicine. 346: 165-73. PMID 11796850 DOI: 10.1056/Nejmoa010994 |
0.312 |
|
| 1998 |
Myers LW, Ellison GW, Merrill JE, El Hajjar A, St Pierre B, Hijazin M, Leake BD, Bentson JR, Nuwer MR, Tourtellotte WW, Davis P, Granger D, Fahey JL. Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase. Neurology. 51: 1483-6. PMID 9818891 DOI: 10.1212/Wnl.51.5.1483 |
0.336 |
|
| 1998 |
Tumani H, Tourtellotte WW, Peter JB, Felgenhauer K. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. Journal of the Neurological Sciences. 155: 44-9. PMID 9562321 DOI: 10.1016/S0022-510X(97)00272-4 |
0.381 |
|
| 1997 |
Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T, Smith RA, Nelson JR, Reynolds WF. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. Journal of Neuroimmunology. 78: 97-107. PMID 9307233 DOI: 10.1016/S0165-5728(97)00089-1 |
0.367 |
|
| 1997 |
Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. Journal of Medical Virology. 52: 301-8. PMID 9210040 DOI: 10.1002/(Sici)1096-9071(199707)52:3<301::Aid-Jmv11>3.0.Co;2-L |
0.339 |
|
| 1997 |
Aquino DA, Capello E, Weisstein J, Sanders V, Lopez C, Tourtellotte WW, Brosnan CF, Raine CS, Norton WT. Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. Journal of Neuropathology and Experimental Neurology. 56: 664-72. PMID 9184657 DOI: 10.1097/00005072-199756060-00004 |
0.346 |
|
| 1996 |
Stoner GL, Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW. Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1: 193-9. PMID 9345433 DOI: 10.1177/135245859600100401 |
0.366 |
|
| 1995 |
Stoner GL, Agostini HT, Ryschkewitsch CF, Baumhefner RW, Tourtellotte WW. JC virus in urine of chronic-progressive multiple sclerosis patients and control individuals Journal of Neuroimmunology. 56: 74-74. DOI: 10.1016/0165-5728(95)99122-Y |
0.328 |
|
| 1995 |
Tourtellotte WW, Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ. Herpesviruses in active plaques of postmortem multiple sclerosis brain tissue Journal of Neuroimmunology. 21-21. DOI: 10.1016/0165-5728(95)98924-Z |
0.343 |
|
| 1994 |
Syndulko K, Singer EJ, Nogales-Gaete J, Conrad A, Schmid P, Tourtellotte WW. Laboratory evaluations in HIV-1-associated cognitive/motor complex. The Psychiatric Clinics of North America. 17: 91-123. PMID 8190671 DOI: 10.1016/S0193-953X(18)30132-1 |
0.301 |
|
| 1994 |
Ellison GW, Myers LW, Leake BD, Mickey MR, Ke D, Syndulko K, Tourtellotte WW. Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group. Annals of Neurology. 36: S108-12. PMID 8017868 DOI: 10.1002/Ana.410360725 |
0.306 |
|
| 1994 |
Conrad AJ, Chiang EY, Andeen LE, Avolio C, Walker SM, Baumhefner RW, Mirzayan R, Tourtellotte WW. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. Journal of Neuroimmunology. 54: 99-108. PMID 7929807 DOI: 10.1016/0165-5728(94)90236-4 |
0.332 |
|
| 1994 |
Singer EJ, Syndulko K, Fahy-Chandon BN, Shapshak P, Resnick L, Schmid P, Conrad AJ, Tourtellotte WW. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. Aids (London, England). 8: 197-204. PMID 7913815 DOI: 10.1097/00002030-199402000-00007 |
0.315 |
|
| 1994 |
Kittur S, Hoh J, Endo H, Tourtellotte W, Weeks BS, Markesbery W, Adler W. Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer's disease patients. I. Decrease in NF-L and NF-M message. Journal of Geriatric Psychiatry and Neurology. 7: 153-8. PMID 7522458 DOI: 10.1177/089198879400700305 |
0.303 |
|
| 1993 |
Fiala M, Singer EJ, Graves MC, Tourtellotte WW, Stewart JA, Schable CA, Rhodes RH, Vinters HV. AIDS dementia complex complicated by cytomegalovirus encephalopathy. Journal of Neurology. 240: 223-31. PMID 8388434 DOI: 10.1007/Bf00818709 |
0.306 |
|
| 1993 |
Syndulko K, Tourtellotte WW, Baumhefner RW, Ellison GW, Myers LW, Belendiuk G, Kondraske GV. Neuroperformance Evaluation of Multiple Sclerosis Disease Progression in a Clinical Trial: Implications for Neurological Outcomes: Neurorehabilitation and Neural Repair. 7: 153-176. DOI: 10.1177/136140969300700310 |
0.303 |
|
| 1990 |
Kittur SD, Kittur DS, Soncrant TT, Rapoport SI, Tourtellotte WW, Nagel JE, Adler WH. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Annals of Neurology. 28: 168-73. PMID 2221845 DOI: 10.1002/Ana.410280209 |
0.358 |
|
| 1989 |
Baumhefner RW, Tourtellotte WW, Syndulko K, Staugaitis A, Shapshak P. Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids. Italian Journal of Neurological Sciences. 10: 19-32. PMID 2925343 DOI: 10.1007/Bf02333869 |
0.369 |
|
| 1989 |
Ellison GW, Myers LW, Mickey MR, Graves MC, Tourtellotte WW, Syndulko K, Holevoet-Howson MI, Lerner CD, Frane MV, Pettler-Jennings P. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology. 39: 1018-26. PMID 2668784 DOI: 10.1212/Wnl.39.8.1018 |
0.335 |
|
| 1989 |
Möller JR, Johnson D, Brady RO, Tourtellotte WW, Quarles RH. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. Journal of Neuroimmunology. 22: 55-61. PMID 2465313 DOI: 10.1016/0165-5728(89)90009-X |
0.399 |
|
| 1988 |
Tourtellotte WW, Baumhefner RW, Syndulko K, Shapshak P, Osborne M, Rubinshtein G, Newton L, Ellison G, Myers L, Rosario I. The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. Journal of Neuroimmunology. 20: 217-27. PMID 3198746 DOI: 10.1016/0165-5728(88)90163-4 |
0.412 |
|
| 1988 |
Ichioka T, Uobe K, Stoskopf M, Kishimoto Y, Tennekoon G, Tourtellotte WW. Anti-galactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA). Neurochemical Research. 13: 203-7. PMID 3133570 DOI: 10.1007/Bf00971533 |
0.381 |
|
| 1988 |
Tourtellotte WW, Baumhefner RW, Shapshak P. Measuring intra-BBB IgG synthesis rate by formula in multiple sclerosis Journal of Neuroimmunology. 17: 262. DOI: 10.1016/0165-5728(88)90091-4 |
0.317 |
|
| 1988 |
Baumhefner RW, Tourtellotte WW, Syndulko K, Ellison G, Myers L, Cohen SN, Shapshak P, Osborne M. Size of multiple sclerosis (MS) plaque volume in cerebrum correlates directly with intra-BBB IgG synthesis rate in vivo Journal of Neuroimmunology. 17: 253-254. DOI: 10.1016/0165-5728(88)90074-4 |
0.36 |
|
| 1987 |
Pardridge WM, Yang J, Eisenberg J, Tourtellotte WW. Isolation of intact capillaries and capillary plasma membranes from frozen human brain. Journal of Neuroscience Research. 18: 352-7. PMID 3694717 DOI: 10.1002/Jnr.490180213 |
0.34 |
|
| 1987 |
Walsh MJ, Shapshak P, Graves MC, Imagawa DT, Tourtellotte WW. Isoelectric point restriction of cerebrospinal fluid and serum IgG antibodies to measles virus polypeptides in multiple sclerosis. Journal of Neuroimmunology. 14: 243-52. PMID 3549773 DOI: 10.1016/0165-5728(87)90012-9 |
0.364 |
|
| 1987 |
Möller JR, Yanagisawa K, Brady RO, Tourtellotte WW, Quarles RH. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis. Annals of Neurology. 22: 469-74. PMID 2449119 DOI: 10.1002/Ana.410220405 |
0.38 |
|
| 1986 |
Shapshak P, Tourtellotte WW, Wolman M, Verity N, Verity MA, Schmid P, Syndulko K, Bedows E, Boostanfar R, Darvish M. Search for virus nucleic acid sequences in postmortem human brain tissue using in situ hybridization technology with cloned probes: some solutions and results on progressive multifocal leukoencephalopathy and subacute sclerosing panencephalitis tissue. Journal of Neuroscience Research. 16: 281-301. PMID 3746947 DOI: 10.1002/Jnr.490160124 |
0.34 |
|
| 1986 |
Walsh MJ, Tourtellotte WW, Shapshak P. Immunoglobulin heavy chain associated protein in multiple sclerosis cerebrospinal fluid. Molecular Immunology. 23: 1117-23. PMID 3099176 DOI: 10.1016/0161-5890(86)90010-6 |
0.323 |
|
| 1985 |
Shapshak P, Tourtellotte WW, Nakamura S, Graves MC, Darvish M, Hoffman D, Walsh MJ, Fareed GC, Schmid P, Heinzmann C. Subacute sclerosing panencephalitis: measles virus matrix protein nucleic acid sequences detected by in situ hybridization. Neurology. 35: 1605-9. PMID 4058750 DOI: 10.1212/Wnl.35.11.1605 |
0.301 |
|
| 1985 |
Tourtellotte WW, Staugaitis SM, Walsh MJ, Shapshak P, Baumhefner RW, Potvin AR, Syndulko K. The basis of intra-blood-brain-barrier IgG synthesis. Annals of Neurology. 17: 21-7. PMID 3985581 DOI: 10.1002/Ana.410170107 |
0.378 |
|
| 1985 |
Walsh MJ, Tourtellotte WW, Roman J, Dreyer W. Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis. Clinical Immunology and Immunopathology. 35: 313-27. PMID 3921302 DOI: 10.1016/0090-1229(85)90092-3 |
0.363 |
|
| 1985 |
Resnick L, diMarzo-Veronese F, Schüpbach J, Tourtellotte WW, Ho DD, Müller F, Shapshak P, Vogt M, Groopman JE, Markham PD. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. The New England Journal of Medicine. 313: 1498-504. PMID 2999592 DOI: 10.1056/Nejm198512123132402 |
0.35 |
|
| 1985 |
Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone. Annals of Neurology. 18: 356-7. PMID 2996418 DOI: 10.1002/Ana.410180316 |
0.345 |
|
| 1985 |
Tourtellotte WW, Staugaitis SM, Walsh MJ, Shapshak P, Baumhefner RW, Potvin AR. The Science of Intra-Blood-Brain-Barrier IgG Synthesis Protides of the Biological Fluids. 32: 161-164. DOI: 10.1016/B978-0-08-031739-7.50042-2 |
0.388 |
|
| 1985 |
Staugaitis SM, Shapshak P, Tourtellotte WW, Lee MM, Reiber HO. Isoelectric focusing of unconcentrated cerebrospinal fluid: Applications to ultrasensitive analysis of oligoclonal immunoglobulin G Electrophoresis. 6: 287-291. DOI: 10.1002/Elps.1150060608 |
0.327 |
|
| 1984 |
Tourtellotte WW, Syndulko K, Jennings P. Use of P300 and a dementia rating scale in the evaluation of cognitive dysfunction in MS. Acta Neurologica Scandinavica. Supplementum. 101: 32-4. PMID 6594913 DOI: 10.1111/J.1600-0404.1984.Tb02548.X |
0.308 |
|
| 1984 |
Tourtellotte WW, Walsh MJ, Baumhefner RW, Staugaitis SM, Shapshak P. The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis. Annals of the New York Academy of Sciences. 436: 52-67. PMID 6398024 DOI: 10.1111/J.1749-6632.1984.Tb14775.X |
0.394 |
|
| 1984 |
Sato S, Quarles RH, Brady RO, Tourtellotte WW. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis. Annals of Neurology. 15: 264-7. PMID 6202231 DOI: 10.1002/Ana.410150310 |
0.377 |
|
| 1984 |
Trotter JL, Wegescheide CL, Garvey WF, Tourtellotte WW. Studies of myelin proteins in multiple sclerosis brain tissue. Neurochemical Research. 9: 147-52. PMID 6201757 DOI: 10.1007/Bf00967666 |
0.344 |
|
| 1984 |
Tourtellotte WW, Shapshak P, Nakamura S, Darvish M, Fareed GC, Hoffman D, Heinzmann C, Sidhu K, Schmid P, Rozenblatt S, Graves MC, Berry K, Tourtellotte WW. 118 The Detection Of Viral Nucleic Acid Sequences In Formalin Fixed Paraffin-Embedded Brain Tissue From Patients With Neurologic Diseases Using In Situ Hybridization Journal of Neuropathology and Experimental Neurology. 43: 332. DOI: 10.1097/00005072-198405000-00124 |
0.319 |
|
| 1983 |
Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. Journal of the Neurological Sciences. 62: 219-32. PMID 6607973 DOI: 10.1016/0022-510X(83)90201-0 |
0.315 |
|
| 1982 |
Yahara S, Kawamura N, Kishimoto Y, Saida T, Tourtellotte WW. A change in the cerebrosides and sulfatides in a demyelinating nervous system. Development of the methodology and study of multiple sclerosis and Wallerian degeneration. Journal of the Neurological Sciences. 54: 303-15. PMID 7097303 DOI: 10.1016/0022-510X(82)90191-5 |
0.325 |
|
| 1982 |
Yu RK, Ueno K, Glaser GH, Tourtellotte WW. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. Journal of Neurochemistry. 39: 464-77. PMID 7086428 DOI: 10.1111/J.1471-4159.1982.Tb03968.X |
0.323 |
|
| 1981 |
Tourtellotte WW, Ma BI, Brandes DB, Walsh MJ, Potvin AR. Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Annals of Neurology. 9: 551-6. PMID 7259117 DOI: 10.1002/Ana.410090607 |
0.321 |
|
| 1981 |
Mehta PD, Frisch S, Thormar H, Tourtellotte WW, Wisniewski HM. Bound antibody in multiple sclerosis brains. Journal of the Neurological Sciences. 49: 91-8. PMID 7205323 DOI: 10.1016/0022-510X(81)90191-X |
0.353 |
|
| 1981 |
Ma BI, Joseph BS, Walsh MJ, Potvin AR, Tourtellotte WW. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes. Annals of Neurology. 9: 371-7. PMID 6452854 DOI: 10.1002/Ana.410090410 |
0.397 |
|
| 1980 |
Yam P, Petz LD, Tourtellotte WW, Ma BI. Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis. Clinical Immunology and Immunopathology. 17: 492-505. PMID 7438567 DOI: 10.1016/0090-1229(80)90145-2 |
0.357 |
|
| 1980 |
Arnon R, Crisp E, Kelley R, Ellison GW, Myers LW, Tourtellotte WW. Anti-ganglioside antibodies in multiple sclerosis. Journal of the Neurological Sciences. 46: 179-86. PMID 7381512 DOI: 10.1016/0022-510X(80)90076-3 |
0.391 |
|
| Show low-probability matches. |